{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-009427","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2022-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.775617+00:00","generated_at":"2026-06-21T01:42:59.764841+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cosmos Health raises $32.5M in registered direct offering and private placement at $11.50/unit","bullets":["Gross proceeds of ~$32.5M from sale of 2,828,320 shares and warrants at $11.50/unit.","Each warrant exercisable immediately at $11.50, expires in 5 years; CEO Siokas participated.","Net proceeds to be used for working capital and general corporate purposes.","A.G.P./Alliance Global Partners sole placement agent; cash fee of 6.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-009427","json":"https://secwatch.observer/filing/0001477932-22-009427.json","markdown":"https://secwatch.observer/filing/0001477932-22-009427.md","text":"https://secwatch.observer/filing/0001477932-22-009427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/0001477932-22-009427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T01:42:59.764841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ede6c2c5bf1958d31d306f7848f2b3d1239f7ec1","claim":"Cosmos Health Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $32,525,680 (effective 2022-12-19).","evidence_excerpt":"On December 19, 2022, Cosmos Health Inc. (“we,” “our,” “us,” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), for a registered direct offering and a concurrent private placement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/0001477932-22-009427-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"$32,525,680"},{"label":"Effective","value":"2022-12-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}